Changeflow GovPing Healthcare USPTO Grants Patent for Intragastric Device
Routine Notice Added Final

USPTO Grants Patent for Intragastric Device

Favicon for changeflow.com ChangeBridge: Patent Grants - Prosthetics (A61F)
Published March 24th, 2026
Detected March 24th, 2026
Email

Summary

The USPTO has granted a patent for an intragastric device designed to restrict gastric capacity. The device, assigned to Servicio Cántabro De Salud Universidad De Cantabria, utilizes a neutral buoyancy principle with an inner core and an outer covering containing fluids at different pressures. This patent grant is a routine administrative action.

What changed

The United States Patent and Trademark Office (USPTO) has granted patent US12582540B2 for an intragastric device. The device is designed to be inserted into the gastric cavity to restrict its capacity and is based on the principle of neutral buoyancy. It comprises an inner core with a chamber and a valve for introducing pressurized fluid, and an outer covering with a cavity and a second valve for introducing a volume of fluid at a different pressure.

This patent grant is a routine administrative action by the USPTO and does not impose new regulatory obligations on regulated entities. It signifies the protection of intellectual property for a novel medical device. Compliance officers should note this as an update in the medical device landscape, particularly for companies involved in bariatric or gastrointestinal interventions.

Source document (simplified)

← USPTO Patent Grants

Intragastric device

Grant US12582540B2 Kind: B2 Mar 24, 2026

Assignee

Servicio Cántabro De Salud Universidad De Cantabria

Inventors

Federico Castillo Suescún, Javier Crespo García, Juan Carlos Rodríguez Sanjuan, Ramón Sancibrián Herrera

Abstract

Intragastric device intended to be inserted into a gastric cavity to restrict its capacity. To contribute to optimal adaptation, its design is based on the principle of neutral buoyancy. The device comprises an inner core and an outer covering (2). The inner core consists of a closed chamber (1) and a first valve (4) connecting the inside of the chamber (1) to the outside, through which a pressurised fluid is introduced into the chamber (1). The outer covering (2) comprises a first cavity (5), in which the core is housed, and a second valve (7), through which a volume of fluid is introduced into the free space of the cavity not occupied by the chamber (1). This fluid in the first cavity (5) is at a different pressure to that of the fluid introduced into the chamber (1).

CPC Classifications

A61F 5/0036 A61F 5/0083 A61F 5/0043 A61F 5/0076 A61F 5/0033

Filing Date

2022-07-06

Application No.

18577478

Claims

17

View original document →

Named provisions

Abstract Assignee Inventors Claims

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
USPTO
Published
March 24th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US12582540B2

Who this affects

Applies to
Drug manufacturers Medical device makers
Industry sector
3345 Medical Device Manufacturing
Activity scope
Medical Device Development
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Product Development
Topics
Medical Devices Patents

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Patent Grants - Prosthetics (A61F) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.